Award
National Heart, Lung, and Blood Institute 5R33HL165366-04
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea
Recipient
Not specified
Award Amount
$4,125,108.00
Ceiling
$4,125,108.00
Awarded
September 06, 2025
Identifier
5R33HL165366-04
NIH grant awarded for a randomized control trial to study oxygen therapy in children and adolescents with Down Syndrome and obstructive sleep apnea, with a focus on efficacy and safety of oxygen supplementation.
Description
This is a NIH grant opportunity for a randomized control trial studying oxygen therapy in children and adolescents with Down Syndrome and obstructive sleep apnea. The project involves multiple clinical sites and aims to evaluate the efficacy and safety of oxygen supplementation.